secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2026-05-14T20:05:32+00:00
Accession:  0001493152-26-023069
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma files 1-for-30 reverse stock split
---------------------------------------------------

- Filed 1-for-30 reverse stock split of common stock on May 11, 2026.
- Fractional shares rounded up; no fractional shares will be issued in the split.
- Ticker symbol remains ASBP; new CUSIP number is 738920305.
- Effective date set in the Certificate of Amendment filed with Delaware Secretary of State.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226023069/0001493152-26-023069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315226023069/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-023069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer